Odronextamab

odronextamab · Regeneron Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for Odronextamab, covering 2025-09-16 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma [Phase 3]

See pricing